Cyclobutanes in Small-Molecule Drug Candidates

被引:116
|
作者
van der Kolk, Marnix R. [1 ]
Janssen, Mathilde A. C. H. [1 ]
Rutjes, Floris P. J. T. [1 ]
Blanco-Ania, Daniel [1 ]
机构
[1] Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6526 AJ Nijmegen, Netherlands
基金
荷兰研究理事会;
关键词
Cyclobutanes; strained carbocycles; conformational restriction; pharmacophores; isosteres; HISTAMINE H-3 RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; APOLIPOPROTEIN-E; GLUCOKINASE ACTIVATORS; BIOLOGICAL EVALUATION; HISTONE MODIFICATIONS; SELECTIVE INHIBITORS; INDAZOLE DERIVATIVES; STRUCTURAL BASIS; POTENTIAL ROLE;
D O I
10.1002/cmdc.202200020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclobutanes are increasingly used in medicinal chemistry in the search for relevant biological properties. Important characteristics of the cyclobutane ring include its unique puckered structure, longer C-C bond lengths, increased C-C pi-character and relative chemical inertness for a highly strained carbocycle. This review will focus on contributions of cyclobutane rings in drug candidates to arrive at favorable properties. Cyclobutanes have been employed for improving multiple factors such as preventing cis/trans-isomerization by replacing alkenes, replacing larger cyclic systems, increasing metabolic stability, directing key pharmacophore groups, inducing conformational restriction, reducing planarity, as aryl isostere and filling hydrophobic pockets.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Small-molecule inhibitors of human mitochondrial DNA transcription
    Bonekamp, Nina A.
    Peter, Bradley
    Hillen, Hauke S.
    Felser, Andrea
    Bergbrede, Tim
    Choidas, Axel
    Horn, Moritz
    Unger, Anke
    Di Lucrezia, Raffaella
    Atanassov, Ilian
    Li, Xinping
    Koch, Uwe
    Menninger, Sascha
    Boros, Joanna
    Habenberger, Peter
    Giavalisco, Patrick
    Cramer, Patrick
    Denzel, Martin S.
    Nussbaumer, Peter
    Klebl, Bert
    Falkenberg, Maria
    Gustafsson, Claes M.
    Larsson, Nils-Goeran
    NATURE, 2020, 588 (7839) : 712 - +
  • [32] Perspectives on the Discovery of Small-Molecule Modulators for Epigenetic Processes
    Lu, Quinn
    Quinn, Amy M.
    Patel, Mehul P.
    Semus, Simon F.
    Graves, Alan P.
    Bandyopadhyay, Deepak
    Pope, Andrew J.
    Thrall, Sara H.
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (05) : 555 - 571
  • [33] Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors
    Panicker, Resmi C.
    Chattopadhaya, Souvik
    Coyne, Anthony G.
    Srinivasan, Rajavel
    PROTEIN ALLOSTERY IN DRUG DISCOVERY, 2019, 1163 : 253 - 278
  • [34] Progress on small-molecule proteolysis-targeting chimeras
    Huang, Wenhai
    Wang, Beibei
    Zhang, Zhimin
    Zhang, Chixiao
    Zeng, Shenxin
    Shen, Zhengrong
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (20) : 2715 - 2734
  • [35] Peptide toxins and small-molecule blockers of BK channels
    Yu, Mu
    Liu, San-ling
    Sun, Pei-bei
    Pan, Hao
    Tian, Chang-lin
    Zhang, Long-hua
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (01) : 56 - 66
  • [36] FDA-approved small-molecule kinase inhibitors
    Wu, Peng
    Nielsen, Thomas E.
    Clausen, Mads H.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (07) : 422 - 439
  • [37] Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer
    Liu, Zhiqing
    Wang, Pingyuan
    Wold, Eric A.
    Song, Qiaoling
    Zhao, Chenyang
    Wang, Changyun
    Zhou, Jia
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) : 4257 - 4288
  • [38] The influence of intramolecular sulfur-lone pair interactions on small-molecule drug design and receptor binding
    Hudson, B. M.
    Nguyen, E.
    Tantillo, D. J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (16) : 3975 - 3980
  • [39] Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development
    El-Sakkary, Nelly
    Chen, Steven
    Arkin, Michelle R.
    Caffrey, Conor R.
    Ribeiro, Paula
    DISEASE MODELS & MECHANISMS, 2018, 11 (07)
  • [40] Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development
    Tan, Xueqiang
    Huang, Zuyi
    Pei, Hairun
    Jia, Zongchao
    Zheng, Jimin
    ISCIENCE, 2024, 27 (09)